Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00724191 · ClinicalTrials.gov registry record
Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 88
- Enrollment target
NCT00724191: Completed study, sponsored by University of Michigan.
NCT00724191 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00724191 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if new MRI methods that measure various information and chemical makeup in the brain, will give early information regarding response to treatment in patients with brain tumors.
Primary Outcome
New treatment response MRI metrics derived from change in water diffusion and perfusion from pre-treatment to mid-treatment will be compared to traditional response metrics measured 4 weeks after completion of standard of care chemoradiation for their prediction of patient outcomes and overall survival. The new response metrics are not only measured earlier, but are also quantitative measures for the fraction of tumor exhibiting significant change in diffusion and perfusion assessed on a voxel-b
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 1999-09 |
| Est. Completion | 2014-01-15 |
What the finished NCT00724191 record still lists
NCT00724191 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT00724191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00724191 about?
NCT00724191 is a clinical study titled "Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)". The purpose of this study is to determine if new MRI methods that measure various information and chemical makeup in the brain, will give early information regarding response to treatment in patients with brain tumors.
What is the current status of trial NCT00724191?
This trial is currently completed. The enrollment target is 88 participants. The study started on 1999-09. Estimated completion is 2014-01-15.
What interventions are being tested in trial NCT00724191?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00724191?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia